| ONO-AE3-208 (sodium salt) |
ONO-AE3-208 (sodium salt) |
2309931-05-1 |
| ABO (hydrochloride) |
ABO (hydrochloride) |
2309172-24-3 |
| 13-PAHSA |
13-PAHSA |
2169306-42-5 |
| Regorafenib-13C-d3 |
瑞戈非尼 -13C-D3 |
2126178-55-8 |
| TCO-PEG12-DBCO |
TCO-PEG12-DBCO |
2055022-06-3 |
| Rp-8-CPT-Cyclic AMP (sodium salt) |
Rp-8-CPT-Cyclic AMP (sodium salt) |
221905-35-7 |
| 4(Z),7(Z),10(Z),13(Z),16(Z)-N-(2-hydroxyethyl)-Docosapentaenamide |
4(Z),7(Z),10(Z),13(Z),16(Z)-N-(2-hydroxyethyl)-Docosapentaenamide |
211817-55-9 |
| 9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
211105-29-2 |
| NF-κB Control |
NF-κB Control |
201608-17-5 |
| 9ALPHA,11ALPHA-DIHYDROXY-15-OXO-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC ACID |
9ALPHA,11ALPHA-DIHYDROXY-15-OXO-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC ACID |
23109-94-6 |
| 2,6-ANS |
2,6-ANS |
20096-53-1 |
| 13C6-3-Nitrophenylhydrazine (hydrochloride) |
13C6-3-Nitrophenylhydrazine (hydrochloride) |
1977535-33-3 |
| MI-nc (hydrochloride) |
MI-nc (hydrochloride) |
1934302-23-4 |
| SLM6031434 |
SLM6031434 |
1897379-33-7 |
| 9-SAHSA |
9-SAHSA |
1895916-79-6 |
| Se-Aspirin |
Se-Aspirin |
1850293-95-6 |
| CAY10702 |
CAY10702 |
1830320-32-5 |
| ND-336 |
ND-336 |
1807453-83-3 |
| Beta-Amyloid (1-40) (S26C) Dimer |
Beta-Amyloid (1-40) (S26C) Dimer |
1802087-75-7 |
| N-(2,5-dichlorophenyl)-4-(furan-2-yl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxamide |
N-(2,5-dichlorophenyl)-4-(furan-2-yl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxamide |
1798310-55-0 |
